ストックスクリーナーアプリを入手
10.68
0.37%
-0.04
前日終値:
$10.72
開ける：
$10.72
24時間の取引高:
3.96M
Relative Volume:
0.88
時価総額：
$7.62B
収益：
$125.68M
当期純損益:
$4.81B
株価収益率:
1.8903
EPS:
5.65
ネットキャッシュフロー:
$-781.21M
1週間 パフォーマンス:
+1.14%
1か月 パフォーマンス:
-5.24%
6か月 パフォーマンス:
-9.41%
1年 パフォーマンス:
-7.45%
1日の値動き範囲:
$10.67
$10.86
1週間の範囲:
$10.55
$10.86
52週間の値動き範囲:
$9.76
$13.05
Roivant Sciences Ltd Stock (ROIV) Company Profile
名前
Roivant Sciences Ltd
セクター
電話
441-295-5950
住所
CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON HM11
ROIV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ROIV
Roivant Sciences Ltd
|
10.68 | 7.62B | 125.68M | 4.81B | -781.21M | 5.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Roivant Sciences Ltd Stock (ROIV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-02-15 | 開始されました | Wolfe Research | Outperform |
| 2024-01-05 | 開始されました | Piper Sandler | Overweight |
| 2023-12-12 | 開始されました | Deutsche Bank | Buy |
| 2023-10-17 | 開始されました | Guggenheim | Buy |
| 2023-06-08 | 開始されました | BofA Securities | Neutral |
| 2022-10-27 | 開始されました | JP Morgan | Overweight |
| 2022-05-23 | 開始されました | SVB Leerink | Outperform |
| 2022-04-29 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-12-15 | 開始されました | Goldman | Buy |
| 2021-11-08 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-28 | 開始されました | Citigroup | Buy |
| 2021-10-26 | 開始されました | Cowen | Outperform |
| 2021-10-26 | 開始されました | Jefferies | Buy |
| 2021-10-26 | 開始されました | Truist | Buy |
すべてを表示
Roivant Sciences Ltd (ROIV) 最新ニュース
Roivant Sciences appoints new Principal Accounting Officer By Investing.com - Investing.com South Africa
Roivant Sciences appoints new Principal Accounting Officer - Investing.com
Roivant Sciences Appoints New Chief Accounting Officer - TipRanks
Will Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So. - The Motley Fool
Insider Selling: Roivant Sciences Ltd. (NASDAQ:ROIV) CAO Sells 227,500 Shares of Stock - MarketBeat
Long Term Trading Analysis for (ROIV) - Stock Traders Daily
Roivant Sciences' chief accounting officer sells $2.37 million in shares By Investing.com - Investing.com Canada
Roivant Sciences’ chief accounting officer sells $2.37 million in shares By Investing.com - Investing.com Nigeria
Roivant Sciences' chief accounting officer sells $2.37 million in shares - Investing.com India
Eric Venker Sells 218,041 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) Stock - MarketBeat
Roivant Sciences president Eric Venker sells over $4.56 million in stock - MSN
Roivant Sciences president Eric Venker sells over $4.56 million in stock By Investing.com - Investing.com South Africa
Roivant Sciences (NASDAQ:ROIV) Shares Gap Up After Earnings Beat - MarketBeat
Roivant Sciences' (ROIV) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
178,853 Shares in Roivant Sciences Ltd. (NASDAQ:ROIV) Acquired by Elevate Capital Advisors LLC - MarketBeat
Roivant Sciences (NASDAQ:ROIV) Posts Quarterly Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat
Roivant Sciences: Earnings Reveal Strategic Clinical Advances - MSN
Roivant Sciences targets brepocitinib expansion with new cutaneous sarcoidosis trial amid $5.2B cash position - MSN
Roivant Sciences price target lowered to $12 from $13 at BofA - Yahoo Finance
Roivant Sciences Ltd. (ROIV): A Cheap Biotech Stock to Invest In Now - Yahoo Finance
Roivant Sciences Insiders Sold US$52m Of Shares Suggesting Hesitancy - Simply Wall St
News Flash: Analysts Just Made A Captivating Upgrade To Their Roivant Sciences Ltd. (NASDAQ:ROIV) Forecasts - Yahoo Finance
Industry Analysts Just Upgraded Their Roivant Sciences Ltd. (NASDAQ:ROIV) Revenue Forecasts By 21% - Simply Wall St
10 Cheap Biotech Stocks to Invest in Now - Insider Monkey
Roivant Sciences Ltd. (NASDAQ:ROIV) Q3 2024 Earnings Call Transcript - Insider Monkey
Roivant Sciences Tops Q3 Expectations - Mitrade
Roivant Sciences Ltd (ROIV) Q3 2024 Earnings Call Highlights: Strategic Moves and Financial ... By GuruFocus - Investing.com Canada
Roivant Sciences: Strong Earnings Call Amid Challenges - TipRanks
Roivant Sciences Ltd. (ROIV) Reports Q3 Loss, Tops Revenue Estimates - MSN
Roivant Sciences Ltd. (ROIV) reports earnings - Quartz
Roivant Sciences earnings beat by $0.48, revenue topped estimates - Investing.com Australia
Roivant Sciences Ltd. (ROIV) Tops Q3 EPS by 48c - StreetInsider.com
Roivant Reports Financial Results for Q3 2024 - TradingView
Roivant Reports Financial Results for the Third Quarter Ended December 31, 2024, and Provides Business Update - The Manila Times
Roivant Sciences Fiscal Q3 Earnings, Revenue Fall -February 10, 2025 at 07:17 am EST - Marketscreener.com
Roivant Sciences Q3 Earnings Assessment - Benzinga
Earnings Flash (ROIV) Roivant Sciences Posts Q3 Revenue $9M, vs. FactSet Est of $5M - Marketscreener.com
Roivant's $5.2B War Chest Fuels Ambitious Clinical Pipeline as Loss Widens in Q3 - StockTitan
Roivant Sciences Ltd. (NASDAQ:ROIV) Shares Sold by DAVENPORT & Co LLC - MarketBeat
Trading (ROIV) With Integrated Risk Controls - Stock Traders Daily
Roivant Sciences (ROIV) to Release Quarterly Earnings on Monday - Defense World
Roivant Sciences Ltd (ROIV) 財務データ
収益
当期純利益
現金流量
EPS
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):